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Abstract 
This paper describes two sensitive and simple spectrophotometric methods for determination of 
famotidine in pharmaceutical preparations. The first method is based on the hydrolisis of famotidine 
with sodium hydroxide assisted with microwave radiation, whereby the sulfide ion is produced. The 
sulfide was allowed to react with N, N – diethyl – p – phenylendiamine oxalate and Fe (III), and the 
blue color produced was measured at 671 nm. Beer’s law was fulfilled in the concentration range 0.6 
– 52.8 µg/ml, with a detection limit of 0.2 µg/ml. The second method is based upon the formation of a 
ternary complex between lead (II), eosin and famotidine in the presence of methyl cellulose as a 
surfactant. The ternary complex showed an absorption maximum at 541 nm. The method obeys 
Beer’s law over concentration range of 7.4-100.0 µg/ml. The methods are simple, sensitive and 
accurate. The proposed method was applied on the famotidine determination in tablets and 
intravenous solution, shows recoveries in the range of 97.9-104.2 %. The results obtained by proposed 
methods were statistically validated. 
Keywords: Famotidine, spectrophotometry, pharmaceutical formulations, hydrolysis, ternary 
complex. 
 
1. Introduction 
Famotidine, 3-[[[2-[(aminoiminomethyl)amino]-
4-thiazolyl]methyl]thiol]-N-aminosulfonyl) (Fig. 
1), is a histamine H2-receptor antagonist that is a 
high potent inhibitor of gastric and acid 
secretion in humans and animals. Famotidine is 
useful in any situation where stomach irritation 
is an issue and ulceration is a concern.  It is 
often used in the treatment of Helicobacter 
infection, inflammatory bowel disease, canine 
parvovirus, ingestion of a toxin that could be 
ulcerating, any disease involving protracted 
vomiting, or chronically in combination with 
medications which may have stomach irritating 
properties1.   
Figure 1.  Chemical structure of famotidine 
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Various analytical methods such as high 
performance liquid chromatography2-4, 
fluorimetry5, capillary electrophoresis6, 
polarography7, voltammetry8, and potentiometry9 
have been reported for the determination of 
famotidine. However, these methods are 
expensive and not available at most quality 
control laboratories. Visible spectrophotometry 
is still considered a convenient and economical 
technique for routine analysis of the drugs in 
pharmaceutical formulations. Famotidine has 
been determined spectrophotometrically based 
on reactions with ninhydrin10, 1,4-
benzoquinone11, and other reagents12-13.  
Due to the presence of amino, amido and 
thioether groups in its structure, this drug 
possesses chelating properties and may interact 
with metal ions14-15. It also has sulfur atoms in 
its structure that allow the hydrolysis of the 
molecule with formation of sulfide ions. On the 
basis of these characteristics, in this paper we 
propose two new methods of spectrophotometric 
analysis. The first method is based on the 
formation of a complex between famotidine, 
eosin and Pb(II).  The second method is based 
on the formation of ethylene blue by reaction of 
sulfide ion derived from famotidine, N,N-
diethyl-p-phenylenediamine oxalate (N,N-DPPD 
oxalate) and Fe(III).  
 
2. Material and methods 
2.1. Apparatus: A Agilent 8453 UV-Vis 
spectrophotometer (Nortwalk, CT, USA) with 
glass cells (l = 1 cm) was used for all 
spectrophotometric measurements. A household 
microwave oven (Daewoo) with a nominal 
maximum power of 1200 W as marked was 
used. 
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2.2. Reagents and materials: All reagents were 
of analytical reagent grade unless stated 
otherwise. Water was purified with a Nanopure 
system (Barnstead, USA). 
Standard solution of famotidine: Famotidine pure 
sample was kindly provided by Elmor Laboratory 
Co., Valencia, Venezuela. Stock solution 
containing 1000 µg/ml of famotidine was 
prepared by exact weighing of the drug and 
dissolution in water. The solution was stable for at 
least 4 weeks if stored in the dark at 4 ºC. 
Working solutions were prepared daily by 
appropriate dilutions. 
Eosin solution: Eosin solution (Fluka, Germany) 
was prepared as 0.1% w/v, aqueous solution. 
Lead (II) solution: Lead solution (2000 µg/ml) 
was prepared dissolving 0,31969 g of lead (II) 
nitrate (Fluka, Germany) in deionized water and 
diluting to 1 l with deionized water. 
Methylcellulose solution: Methylcellulose 
solution (Riedel-de Haen) was prepared as 0,5% 
w/v in water with the aid of heat. 
N,N-DPPD oxalate solution: Prepared by 
dissolving 0.5000 g of N,N-DPPD oxalate 
(Fluka, Germany)  and diluting to 50 ml with 1:1 
sulfuric acid. 
Ammomium iron (III) sulfate solution 0.21 M: 
Prepared by dissolving 5.0000 g of 
NH4Fe(SO4)2.12H2O and diluting to 50 ml with 
1.0 M sulfuric acid. 
2.3. Procedure 
2.3.1. Method 1: Spectrophotometric method 
based on ternary complex formation 
Appropriate volumes of the standard solutions 
were placed in a series of 10 ml volumetric 
flasks. A 2.0 ml of the buffer solution pH 3.0, 
1.5 ml of methyl cellulose, 1.0 ml of eosin 
solution and 1.0 ml of lead (II) solution were 
added to the flasks, in this order. The mixture 
was diluted to volume with water and 
homogenized by shaking. Each solution was 
allowed to stand for 8 min at room temperature 
(25 ± 3 ºC). The absorbance was measured at 
500 nm against a reagent blank treated similarly 
2.3.2. Method 2: Spectrophotometric method 
based on ethylene blue formation 
To a PTFE reactor, a 1.0 ml volume of the 
sample solution, 1.0 ml of water and 6.0 g of 
NaOH were added. The reactor was placed 
inside the domestic microwave oven irradiated 
at 1100 W power for 60 s. The content of the 
reactor were transferred to a 100 ml volumetric 
flask and was diluted to volume with deionized 
water. 2.0 ml of the diluted solution was placed 
in a 50 ml volumetric flask, to which 5.0 ml of 
0.05 M H2SO4, 0.5 ml of N,N-DPPD oxalate 
solution and 0.5 ml of NH4Fe(SO4)2 was 
sequentially added. The mixture was diluted to a 
final 50 ml volume with deionized water, shaken 
and allowed to stand for 10 min. The absorbance 
was measured at 670 nm against a reagent blank. 
 
3. Results and discussion 
3.1 Method 1: The reactions of formation of 
ternary complex in which a central metal ion is 
coordinated to two ligands have been widely 
used in spectrophotometric analysis. These 
reactions have found extensive application in the 
determination of different drugs16. The 
particularity of the ternary complex in this study 
is that the first ligand is famotidine, the second 
ligand is eosin, and the ion metal is lead (II). 
The ternary complex has higher value of molar 
absortivity than blank solution formed by eosin 
and lead (II) producing a red color with 
maximum absorbance value at 541 nm (Fig. 2). 
Different metals were also studied to choose the 
most suitable one for formation of ternary 
complex, e.g. Fe(III), Cu(II), Ni(II), Pd(II) and 
Pb(II). The latter was found to have the highest 
absorbance value.  
Figure 2. Absorption spectrum of the ternary 
complex of famotidine  with eosin and lead(II). 
 
Preliminary experiments were carried out to 
optimize the main parameters affecting the 
development and stability of the colored 
complex investigated.  
The effect of pH was investigated by changing 
the pH in the range 3.0 – 6.0. Maximum 
absorbance value was achieved at pH 3.0, using 
2.0 ml of 0.1 M acetate buffer. Other buffers 
having the same pH value such as phosphate and 
phthalate were tried and compared with acetate 
buffer. Among different buffers solution tested, 
the use of acetate buffer resulted in the highest 
absorbance value.  Thus, 0.1 M acetate was 
chosen as buffer system in this investigation. 
The selection of an appropriate surfactant is of 
major importance for the optimization of the 
spectrophotometric method. In this study three 
surfactant namely, triton X-100, methylcellulose 
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and sodium dodecylsulfate were tested. Among 
different surfactant studied, best results were 
obtained in the presence of methylcellulose. We 
investigated the effect of the 0.5% w/v 
methylcellulose volume on the absorbance of the 
complex. The response increased when the 
methylcellulose volume increased from 0.25 -1.5 
ml while larger volumes produce decrease in the 
response (Fig. 3). The addition of 1.5 ml of 0.5%  
w/v methylcellulose ensured the maximum 
response for famotidine complex. 
Figure 3. Effect of volume of 0.5% w/v 
methylcellulose on the absorbance value of the 
ternary complex of famotidine at pH 3.0. 
In order to set an optimal volume of the eosin 
reagent, a range of 0.25 - 2.0 ml of 0.1% w/v 
eosin volumes were tested. Increasing the 
volume of eosin in the range 0.25 – 1.0 ml 
improved the absorbance value of the ternary 
complex while the response remains constant at 
higher amounts of eosin (Fig. 4). For this reason 
1.0 ml of 0.1% w/v eosin was used for the rest of 
the experiments. 
Figure 4. Effect of eosin volume on the absorbance 
value of the ternary complex of famotidine. 
 
The effect of volume of Pb(II) on the absorbance 
of the complex was also studied keeping the 
concentration of the famotidine and eosin 
constant. As shown in Fig. 5, it was observed 
that increasing the volume of 2000 µg/ml of 
Pb(II) result in a gradual increase in the 
absorbance up to 1.0 ml, after which the 
absorbance of complex began to decrease. Thus, 
1.0 ml of 2000 µg/ml of Pb(II) which resulted in 
a final concentration of 200 µg/ml was used in 
this investigation. 
Figure 5. Effect of volume of 2000  µg/ml lead(II) 
on the absorbance value of the ternary complex of 
famotidine at pH 3.0. 
In order to examine the effect of temperature on 
the absorbance of the ternary complex, the 
experiment was carried out at temperature range 
25 - 70 °C, using thermostatic water bath for 10 
min. The solution was cooled to ambient 
temperature before measuring the absorbance. 
Maximum absorbance was obtained at ambient 
temperature (25 ± 2 °C). Higher temperatures 
decrease the absorbance sharply.  
The sequence of addition of reactants can 
influence the formation of coloured product. 
Twelve procedures with different orders of 
component addition were examined. Thus, the 
sequence buffer-famotidine-methylcellulose-
eosin-lead gave higher values of absorbance. 
3.2 Method 2: The proposed method is based on 
the hydrolysis of famotidine with NaOH to give 
sulfide, which is then reacted with N,N-DPPD 
and Fe(III) to form ethylene blue. The reaction is 
an oxidative coupling of two aromatic rings17. 
The absorbance of the blue product at 671 nm is 
proportional to the concentration of famotidine. 
The effects of experimental parameters on the 
hydrolysis of famotidine, such as NaOH amount, 
the radiation power supplied, reaction hydrolysis 
time and total volume of reagents were studied 
using PTFE reactors.  
To investigate the effect of microwave 
irradiation on the hydrolysis of famotidine, 
irradiation time of 15 s was used for microwave-
assisted hydrolysis at 800 W irradiation powers. 
For the purpose of comparison, hydrolysis was 
also performed using a water bath with a 
reaction time of 30 min at 80 °C. The results 
show that although conventional heating is an 
appropriate way to make alkaline hydrolysis of 
famotidine, a relatively long hydrolysis time of 
about 30 min was still required for the 
completion of the reaction. Moreover, the 
absorbance obtained with the hydrolysis assisted 
by microwave radiation was higher than that 
obtained using the water bath. The experimental 
results obtained demonstrated that the speed of 
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alkaline hydrolysis can be significantly 
increased by using microwave heating.  
To study the effect of NaOH amount on the 
hydrolysis yield of famotidine, experiments 
were carried out at a power level of 800 W and 
using an irradiation time of 20 s. As shown in 
Fig. 6, an increase in NaOH provides an increase 
in the absorbance up to 6.0 g after which the 
absorbance of blue compound began to decrease. 
The addition of 6.0 g of NaOH ensured the 
maximum response for famotidine. 
Figure 6. Effect of NaOH amount on the 
hydrolysis yield of famotidine. 
The effect of the irradiation time was studied 
among 10-90 s. The hydrolysis yield increased 
with time increased in the range 10-60 s. 
However, above 60 s, the hydrolysis yield 
decreases (Fig. 7). Thus, 60 s was chosen as 
irradiation time. 
Figure 7. Effect of the irradiation time on the 
hydrolysis yield of famotidine. 
 
The effect of radiation power on the hydrolysis 
of famotidine was studied in the range 330-1100 
W, using an irradiation time of 60 s in the 
presence of 6 g of NaOH. Absorbance of 
ethylene blue increases with increased radiation 
power (Fig. 8). We chose a radiation power of 
1100 W. 
Figure 8. Effect of the radiation power on the 
hydrolysis yield of famotidine. 
 
 
3.3 Application and validation of the proposed 
methods: Using the above mentioned 
spectrophotometric procedures, linear regression 
equations were obtained over the concentration 
ranges stated in Table 1. Two replicates were 
used for each of six prepared standards to obtain 
each calibration graph. The good linearity of the 
calibration graphs is clearly evident from the 
values of regression coefficients.  
In order to evaluate the precision of the 
proposed methods, solutions containing three 
different concentrations of the stated drugs were 
prepared and analysed in five replicates. The 
analytical results obtained from this 
investigation are summarized in Table 1. The 
low values of the relative standard deviation 
(R.S.D.%) indicate the high precision of the 
proposed methods (Table 1). 
 
Table 1. Analytical parameters 
 Method 1 
(ternary complex formation) 
Method 2 
(Ethylene blue formation) 
λ max (nm) 541 671 
Linearity range (µg/ml) 7.4 – 100.0 0.6 – 52.8 
Correlation coefficient 0.998 0.999 
Intercept (a) 0.0280 0.0019 
Slope (b) 0.0077 0.0133 
Detection limit (µg/ml) 2.2 0.2 
Quantification limit (µg/ml) 7.4 0.6 
Repeatibility  
(R.S.D.,%), n = 10 
  
 4.8 (8.0 µg/ml) 4.5 (6.6 µg/ml) 
 2.4 (40.0 µg/ml) 2.6 (26.4 µg/ml) 
 0.8 (100.0 µg/ml) 2.3 (52.8 µg/ml) 
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The influence of commonly used tablet and 
lyophilized powder excipients (lactose, starch, 
magnesium stearate, talc, mannitol, titanium 
dioxide and microcrystalline cellulose) was 
investigated before the determination of the drug 
in dosage forms using the standard addition 
methodology. Student’s t-test shows the 
similarity of the slope of standard calibration 
and standard addition calibration and therefore 
no interference could be observed with the 
proposed methods. 
Samples of commercial dosage forms were 
fortified with different levels of famotidine. 
Table 2 shows results of the study of recovery. 
Validation of the proposed method for these 
samples was tested by using a recovery test 
(Student t-test)18.  As the P-values calculated in 
all cases are greater than 0.05, the null 
hypothesis appears to be valid, i.e., recoveries 
are close to 100% (Table 2). 
Table 2. Results of recovery assays to check the accuracy of the proposed method. 
Method Sample Spiked 
(µg/ml) 
Found # 
(µg/ml) 
Recovery 
( % ) 
t P* 
Method 1 Tablets-40 mg 12.0 12.06 ± 0.13  100.5 1.05 0.35 
18.0 17.87 ± 0.14 99.3 2.01 0.12 
24.0  23.87 ± 0.28  99.5 1.07 0.34 
Tablets-10 mg 10.0  10.09 ± 0.16 100.9 0.94 0.39 
15.0  15.04 ± 0.12  100.3 0.85 0.44 
Powder-20 mg  
 
20.0  20.03 ± 0.17  100.2 1.04 0.35 
10.0  10.06 ± 0.13  100.6 1.05 0.35 
powder-20 mg 15.0 14.94 ± 0.14  99.6 1.72 0.15 
20.0  19.98 ± 0.45  99.9 0.21 0.84 
Method 2 Tablets-40 mg 6.0  6.25 ± 0.25  104.2 2.24 0.09 
9.6  9.51 ± 0.55  99.1 0.34 0.75 
12.0  12.33 ± 0.31  102.7 2.43 0.07 
Tablets-10 mg 6.0  6.17 ± 0.14  102.8 2.70 0.06 
9.6  9.40 ± 0.42  97.9 1.08 0.34 
Powder-20 mg  
 
12.0  12.43 ± 0.50  103.9 1.83 0.15 
8.0 8.12 ± 0.30  101.5 0.92 0.41 
powder-20 mg 12.8 12.85  ± 0.45  100.4 0.27 0.79 
16.0  16.21 ± 0.31  101.3 1.51 0.20 
# Average value ± standard deviation of five determinations. 
* P value of the one-sample comparison test. 
 
The applicability of the proposed methods was 
tested by the determination of famotidine in 
tablets and lyophilized powder. The results 
obtained were presented in Table 3. The values 
reported by manufacturers are located within the 
confidence intervals at 95% confidence level, 
indicating that there is no significant difference   
between the values experimental and nominal. 
These results demonstrate the usefulness of the 
proposed methods for this application. 
Table 3. Determination of famotidine in pharmaceutical formulations by the suggested 
spectrophotometric methods. 
 
Preparations Nominal 
composition 
Found (mg)* 
     Method 1               Method 2 
Tablets 40 mg 39.93  ± 0.30  41.25  ± 1.36  
Tablets 10 mg  9.96  ± 0.57   9.93  ± 0.50  
Lyophilized 
powder 
20 mg 
 
 20.05 ± 0.63   19.88 ± 0.70  
 
*Average value ± 95% confidence interval of five determinations. 
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4. Conclusion 
Two new spectrophotometric methods for the 
determination of famotidine in dosage forms are 
presented. They are quite simple and do not 
require tedious extraction procedure. The 
methods have wider linear range with good 
accuracy and precision. The present methods are 
useful and convenient for quality control and 
routine determination of drugs in pharmaceutical 
dosage forms.  
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